Researchers discover potentially cancer-fighting T cells within some pediatric brain tumor patients
"These patients may be candidates in whom immunotherapy has the potential to show clinical benefit."
Stay updated with breaking news from Ciro Ram. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"These patients may be candidates in whom immunotherapy has the potential to show clinical benefit."
"These patients may be candidates in whom immunotherapy has the potential to show clinical benefit."
E-Mail IMAGE: People with severe COVID-19 manifestations may be left with more of the protective "memory " T cells needed to fight reinfection. view more Credit: La Jolla Institute for Immunology LA JOLLA, CA--A big question on people's minds these days: how long does immunity to SARS-CoV-2 last following infection? Now a research team from La Jolla Institute for Immunology (LJI), The University of Liverpool and the University of Southampton has uncovered an interesting clue. Their new study suggests that people with severe COVID-19 cases may be left with more of the protective ...